NBTB NBT BANCORP
Financials · Russell 2000
Next earnings: Mon 25 Jan 2027 · estimated
What 9 analyst firms say about NBT BANCORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8015
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041
Recent analyst activity · last 90 days
Our tracked history has 7 reports on NBTB from 5 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Piper Sandler raised its target from $56.00 (set 26 Jun 2026) to $61.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Brean Capital | Daniel Cardenas | Hold | 9 Oct 2026 | — |
| DA Davidson | Jake Civiello | — | 29 Oct 2026 | 62.00 USD |
| Hovde Group | Feddie Strickland | Hold | 28 Jul 2026 | 54.00 USD |
| Janney Montgomery Scott | Unnamed analyst | Hold | 23 Feb 2026 | — |
| Keefe Bruyette & Woods | David Konrad | Hold | 30 Oct 2026 | 55.00 USD |
| Piper Sandler | Manuel Navas | Buy | 28 Oct 2026 | 56.00 USD · 26 Jun 2026 |
| Stephens | Matthew Breese | Hold | 30 Jul 2026 | 55.00 USD |
| Weiss Ratings | Unnamed analyst | — | 19 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 10 Feb 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:49 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.